Skip to main content
Lyrea avatar

Not yet reviewed — this article is pending editorial review by Lyrea.

Citation noticeOur citation system is being overhauled

References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.

DALT

This article is a stubmissing:
Interactions
Tolerance
Harm Potential
Legality
DALT molecule structureDALT molecule structure
Chemical Class

DALT is a tryptamine derivative and psychedelic that has been identified as a designer drug. It was first described in the scientific literature by Stephen Szara and colleagues by 1962, and has been used as an intermediate in the preparation of radiolabeled DET. Its analogues include 4-HO-DALT, 4-AcO-DALT, 5-MeO-DALT, and several other allyl-substituted tryptamines.

Dosage & Duration

Dosage

Doses are population estimates that vary widely between individuals.

Threshold~20 mg
Light20-40 mg
Moderate40-60 mg
Strong60+ mg

Shulgin reports exploring DALT up to 42 milligrams, reaching only a +1 in an hour with a return to baseline at the fourth hour; TiHKAL states the dose is greater than 40 mg orally with unknown duration.

Duration

Onset15-45 minutes
After Effects1-4 hours
Total3-6 hours

Subjective Effects

Legacy content. A statistically backed ontology from Mindstate Design Labs is coming soon.

Reports describe a stimulating tryptamine state combining euphoria and emotional openness with mild perceptual change. Self-experimentation up to 42 mg orally produced only a threshold-level effect that peaked within an hour and returned to baseline by the fourth hour, with no features the experimenter found notable. Early accounts group its activity with that of other short-acting tryptamines such as DMT and DET, describing rapidly developing sympathomimetic effects alongside perceptual, emotional, and thinking disturbances.

Physical

Both mental and physical stimulation are reported, accompanied by restlessness, muscle tension, sweating or chills, decreased appetite, pupil dilation, and difficulty sleeping.

Muscle tension

Autonomic

Pupil dilation

Cognitive

The headspace is described in terms of euphoria, empathy, insight, and ego softening, though confusion and general alterations in perception are also reported.

Confusion

Emotional

Euphoria

Visual

Visual effects reported are modest, limited to colour brightening and visuals with the eyes both open and closed.

Hallucinatory States

Tactile

Pharmacology

Pharmacodynamics

The receptor interactions of DALT have been studied, though specific targets are not detailed. In rodents, DALT produces the head-twitch response, a behavioral proxy for psychedelic effects.

Pharmacokinetics

Absorption & half-lifenot documented yetMetabolitesnone documented yet

Interactions

Interactions not written up yet

An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.

Check TripSit

Tolerance

Tolerance not written up yet

Harm Potential

Harm Potential not written up yet

History & Culture

DALT was documented by Alexander Shulgin as entry #57 in TiHKAL, where the synthesis proceeded through the quaternary salt N,N,N-triallyltryptammonium iodide. Treatment of that salt with phenylmercaptan and sodium hydroxide in refluxing acetone, followed by acid-base workup, distillation, and

Trip Reports

Loading related reports

Preparing section content

Still loading. Refresh if this section does not appear.

Legality

Legality not written up yet

Article Status

  • Josie Kins avatar
    Step 1 · Automated synthesis

    An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

  • Step 2 · First-pass reviewPending

    Not yet reviewed — this article is pending editorial review by Lyrea.

  • Step 3 · Citation reviewPending

    No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Recent changes7 human edits · latest

Times are UTCNewest first

24 January 2026

  1. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  2. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  3. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  4. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  5. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  6. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  7. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

All changes to this article · Site-wide recent changes

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the DALT article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.